Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

2018’s full agenda

Plenary Keynote
08:30 - 09:00
Will we succeed with Patient Centricity? Look in the mirror!
  • How to see the mountain: another Golden Rule
  • Why an internal focus can generate external results
  • Culture eats strategy for breakfast

Servier Lode Dewulf Chief Patient Officer Servier

09:00 - 09:30
Panel: Why policy makers are now advancing patient centricity - and why you need to step up accordingly
  • Why NICE are innovating Market Access through patient involvement
  • How patient groups can build a bridge between regulators and payers to increase access
  • Understand EUnetHTA's strategy to elevate the patient voice in HTAs

Takeda Isabel Torres Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada, Takeda

Lundbeck Anders Lassen Head of Regulatory Science & Advocacy Lundbeck

Astellas Stefan Holmstrom Global Head, HTA Strategy Astellas

EUnetHTA Niklas Hedberg Chair of Executive Board EUnetHTA

08:30 - 09:00
A strategic approach to inspire real change
  • Create solutions that meet real needs - understand how to find the right balance between cross-functional trade-off, resource allocation
  • Shift our organizational model - execute training to deliver outcomes, whereby every new project starts with patients in mind, and its success is measured from their perspective
  • Bringing this into practice – Pilot project or patient stakeholder

Ipsen Isabelle Bocher-Pianka Chief Patient Affairs Officer Ipsen

Section 1: Partner For Patient Centricity
08:30 - 09:00
The Business Case for long-term partnership with Patient Groups
  • Sustainable change: invest to strengthen the collaboration and improve trust with the patient community
  • How to shift from transactional value to deeper partnerships with patient groups
  • EPALCO Case Study: The Story of Novartis Oncology Region Europe on how working together with the Patient groups can improve outcomes for patients and make the industry a trusted partner

Novartis Oncology Europe Veronica Foote Head of Patient Relations & Communications Europe Novartis Oncology Europe

09:30 - 10:00
Want to improve patient outcomes? Collaborate with your competitors!
  • Why open-business models are the only way to reduce waste and achieve true change
  • Why pharma must work together to identify gaps in treatment pathways
  • Case Study: How AstraZeneca built a coalition for change

AstraZeneca Tim Scrivener Solution Architect and Data Scientist AstraZeneca

digitalECMT, Cancer Research UK and The Christie NHS Foundation Trust Jenny Royle Patient-centricity Program Lead digitalECMT, Cancer Research UK and The Christie NHS Foundation Trust

09:30 - 10:00
Panel: Accelerate the implementation of outcomes-focused value-based healthcare in Europe
  • Explore how the Innovative Medicines Initiative’s (IMI) Big Data For Better Outcomes (BD4BO) programme is facilitating collaboration across the healthcare landscape
  • Highlight the role and benefits of patients to improve health outcomes and contribute to the sustainability of healthcare systems
  • Discuss the development and utility of standardised patient outcomes measures

ABPI Shahid Hanif Head of Health Data & Outcomes ABPI

Christoph Thalheim Director External Affairs European Multiple Sclerosis Platform (EMSP)

Janssen Christina Donatti IMI Lead, Real-World Evidence Janssen

09:30 - 10:00
MS in the 21st Century; explore a unique collaboration between patients and healthcare professionals to address areas of unmet need in Multiple Sclerosis
  • Understand the ‘communication gap’ that exists between patients and healthcare providers (HCPs) with respect to disease management
  • See the programmes and publications the group has undertaken to address discovered unmet needs
  • Hear the patient perspective; why is this initiative so important for both patients and HCPs?

Merck Group Vanessa Pott Director, Patient Advocacy & Strategic Partnerships, Global Healthcare Government & Public Affairs Merck Group

David Yeandle, OBE Member MS in the 21st Century Patient Steering Group

Section 2: Evidence for Patient Centricity
09:00 - 09:30
Advance market access through patient data and collaborations
  • How do you work with patients to capture patient reported outcomes?
  • What is the impact of PROs on Access dossiers?
  • Build trust through transparency to win the support of the patient

Janssen Global Services LLC Chenglong Han, MD, PhD. Director, Patient-Reported Outcomes, Global Market Access Janssen

09:00 - 09:30
Patient Privacy and GDPR - get it right and harness data for increased value
  • Understand the impact of GDPR on pharma’s ability to build data-driven services
  • How to evaluate the business of investing in AI and other data-dependent strategies
  • Take a step back: are data-driven strategies really the best way to meet patient needs?

Speaker to be announced

09:30 - 10:00
Maximise your data strategy for patient-centric service design
  • Define your data needs to prove internal and external value
  • How to mix internal capability, digital tools and partnerships to meet your data strategy
  • Learn how to transform insights into patient centric impact

Takeda Sanja Njegic Head of Patient Advocacy and Integrated Care Strategy, Europe and Canada Takeda

Im-patient Summit – where patients are in charge!#impatientconf
09:00 - 09:30
Chairman’s Opening:

Matt will kick off the first ever im-patient conference with a message of inclusivity and why this is such an important step forward.

Chairman: -- Matt Eagles Patient Advocate

09:00 - 09:30
Innovation that works – when patients devise their own solutions

Patients suffering from chronic conditions often develop useful and innovative solutions to help them cope with their health disorders. If shared, these patient innovations could significantly impact the lives of others living under similar conditions.

  • Understand the huge scale of patient innovations that require support
  • The patient knows best – understand how empowerment can lead to pre-backed solutions
  • Witness some of the most exciting selections from the 1600 patient-led innovations submitted to an open online platform

Pedro Oliveira Pedro Oliveira Professor of Technology and Innovation Management, Católica Lisbon School of Business & Economics and Leader of Patient Innovation

09:30 - 10:00
Lise Pape, Carer and Founder of Walk With Path

Lise founded Walk With Path in 2014 when she identified a need through her personal experience with Parkinson’s suffered by her father. She used her Innovation Design Engineering background and the company launched its first product in 2017; Path Finder, a visual cueing shoe attachment to help those with Parkinson's. The second product, a haptic feedback insole to improve balance; Path Feel, is in development. Lise will share:

  • How she created a solution to this unmet need of many patients with Parkinson’s and other disease areas
  • Her approach to user centred design, critique of everyday wearables and her approach to co-creation.
  • Feedback and redesign: how patient experiences informed continued improvements.

Lise Pape Lise Pape Carer and Founder Walk With Path

09:30 - 10:00
Develop solution for day to day disease management

Let Andrew fly you on board his ‘blood sugar plane’, rising high and dipping low, in order that you can experience a real patient journey and the challenges that had to be overcome.

  • How recognition of a real patient experience led to the creation of a life-changing technical solution and better
  • How a patient’s decision-making process depends on good data feedback and impact on QOL

Andrew Warrington Andrew Warrington Type 1 Diabetes Patient

Interactive Roundtables
09:30 - 10:00
Interactive Roundtable:Scenario one: The clinical trial engagement roundtable debate

Every pharma executive wants to design clinical trials around patients – yet, consistently, we fail. It’s not due to a lack of budget – it’s a lack of strategy and understanding. Let’s start with the patient perspective and then progress to how we work with external partners.

  • Hear directly from patients on their preference for working with pharma clinical teams, and how do patients prefer to work with them
  • What is most effective at connecting and recruiting patients for the right clinical trials?
  • How can we work with external organisations better to locate trial patients better?
  • Where do external companies (e.g. Clara Health, CureClick etc.) need to improve, and how can patients help?
  • What innovations can pharma introduce to make the traditional RCT more effective for end users?
Interactive Roundtable:Scenario two: The pharmaceutical marketing roundtable debate

Pharma companies are well known for their impressive marketing and advertising budgets, but everybody knows that not all of that money is well spent. Let’s talk to patients about what resonates with them in pharmaceutical advertising and marketing — and what doesn’t.

Marketing Roundtable topics to be announced shortly

Roundtable moderators:

-- Cecile Tardy-Srinivasan Patient Advocate

-- Matt Eagles Patient & Patient Advocate

-- Simon Stones Patient Advocate

-- Richard Stephens Patient Carer

Logo Blank Margot Vanfleteren Patient Advocate

Emma Lawton Emma Lawton Devices Apps & Gadgets Strategist Parkinsons UK

-- Andrew Warrington Type 1 Diabetes Patient

-- Dom Raban Founder Xploro

-- Lisa Mackenzie Patient

Lise Pape Lise Pape Carer and Founder Walk With Path

09:30 - 10:00
Stakeholder Panel
09:30 - 10:00
Stakeholder PanelAdherence is always one of pharma’s goals. But is it the patient’s goal, too?
  • Start with the patient: Align with the patient community’s aspirations and life goals in order to improve treatment compliance and outcomes
  • What tools do patients crave? How to focus investments on demand rather than your technology or convenience
  • Educate adherence: enable more informed decision-making by enabling HCPs to aid transparency and communication with patients

-- Lisa Mackenzie Patient

-- Ben Harman Jones HCP

-- Emma Sutcliffe and her daughter Delilah

09:30 - 10:00
Digital Solutions
09:30 - 10:00
How a patient-inspired app is using AR, AI and game mechanics to deliver health information to children

In 2011, Dom Raban’s 13-year-old daughter, Issy, was diagnosed with a rare form of bone cancer. See how Issy’s year-long journey – involving 18 rounds of chemotherapy, surgery and Proton Therapy in the US – inspired a new mobile application:

  • The challenges of the complex patient journey, especially in children, and finding solutions to the information needs
  • How Issy’s experience led to an app using a variety of new technologies to deliver health information directly to children
  • How patients can lead the development process to improve quality, relevance and advocacy

-- Dom Raban Founder Xploro

09:30 - 10:00
The power of digitally-enhanced communication in the hands of the patient

See how Emma’s Parkinson’s diagnosis, at the age of 29, has led to a new support platform for thousands of patients. Making it her mission to raise awareness about the condition and continue her life as planned, Emma campaigned on social media, published her own book, featured in a BBC documentary and video-blogged her life for a whole year.

  • Witness how Emma’s experience has led to the creation of Threesixfives, a website where people with long term health conditions can learn and find support
  • Understand patient literacy and the potential reach of good storytelling
  • How Parkinson’s UK is using technology to enhance lives – and the opportunity for pharma

Emma Lawton Emma Lawton Devices Apps & Gadgets Strategist Parkinsons UK

09:30 - 10:00
Followed by a Q&A with Dom and Emma, Moderated by Simon Stone

Moderator: -- Simon Stones Patient Advocate

-- Dom Raban Founder Xploro

Emma Lawton Emma Lawton Devices Apps & Gadgets Strategist Parkinsons UK

Section 3: Structure for Patient Centricity
09:00 - 09:30
Discover the organisational blueprint for scaling patient centricity
  • Smart ways to ensure a grassroots movement into a new way of working
  • Build organisational confidence to embed patient engagement into everything you do
  • Case Study: The story of Janssen’s hub for scaling patient engagement

Janssen Pharmaceutical NV. Daniel De Schryver Patient Engagement and Advocacy Lead, Europe, Middle East and Africa Janssen

Jeremy Taylor Patient Advocate

09:30 - 10:00
Panel: Involve the patient voice while staying within industry rules
  • Learn to engage and speak with patients
  • Earn the trust of patients and retain the trust of colleagues and regulators
  • Balance internal investment and external partnerships to harness patient insights
  • How to negotiate tensions between industry rules and patient advocates and groups

NCRI Richard Stephens Consumer Lead and Chair of Consumer Forum NCRI

Carol Munt Patient Advocate

More speakers to be confirmed…

Section 4: Patient Experience for Patient Centricity
09:00 - 09:30
Create services that resonate through co-creation and ethnography
  • Dig beneath the surface to truly understand the patient
  • Shift from patternistic design to co-creation led by patients
  • Move from a business model framework to a patient experience framework of service design

Pfizer Geoff Rollason Patient Experience and Service Director - Oncology UK Pfizer

09:00 - 09:30
Design for Patients As People
  • Generic programs fail fast: Create responsive programs for the full spectrum of patient needs
  • Develop a master plan for segmented engagement
  • Create new mechanisms to incorporate feedback into service delivery

Speaker to be confirmed…

08:30 - 09:00
Explore how Pfizer are vitalising patient engagement through co-created digital innovation
  • Identify what ‘improve delivery of healthcare’ will mean for the quality of patient care
  • Accelerate digital progress through collaboration to understand patient preferences

Doris Christiane Schmitt Consulting and Training Doctor-Patient-Communication

Pfizer Christina Claussen Director Alliance Management & Patient Relations for Corporate Affairs Pfizer

09:00 - 09:30
Panel: Candid patient perspectives on the good, the bad and the ugly of service design
  • How do patients really experience pharma’s services?
  • Can pharma better build trust with patient communities to develop productive collaborations?
  • Innovation is supposedly the ‘silver bullet’, but where do patients really see the opportunity for change?

Speaker_Logo Teresa Ferrairo Patient Advocate

Trishna Bharadia Patient Advocate eyeforpharma Award Winner

Carole Sian Scrafton MBS, BA (hons) Patient Advocate

AISC Paola Antonini, MD, PhD AISC Scientific Committee Member, Head of Clinical Research & Training Initiatives AISC

More speakers TBA

Plenary Keynote
08:30 - 09:00
Will we succeed with Patient Centricity? Look in the mirror!
  • How to see the mountain: another Golden Rule
  • Why an internal focus can generate external results
  • Culture eats strategy for breakfast

Servier Lode Dewulf Chief Patient Officer Servier

09:00 - 09:30
Panel: Why policy makers are now advancing patient centricity - and why you need to step up accordingly
  • Why NICE are innovating Market Access through patient involvement
  • How patient groups can build a bridge between regulators and payers to increase access
  • Understand EUnetHTA's strategy to elevate the patient voice in HTAs

Takeda Isabel Torres Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada, Takeda

Lundbeck Anders Lassen Head of Regulatory Science & Advocacy Lundbeck

Astellas Stefan Holmstrom Global Head, HTA Strategy Astellas

EUnetHTA Niklas Hedberg Chair of Executive Board EUnetHTA

08:30 - 09:00
A strategic approach to inspire real change
  • Create solutions that meet real needs - understand how to find the right balance between cross-functional trade-off, resource allocation
  • Shift our organizational model - execute training to deliver outcomes, whereby every new project starts with patients in mind, and its success is measured from their perspective
  • Bringing this into practice – Pilot project or patient stakeholder

Ipsen Isabelle Bocher-Pianka Chief Patient Affairs Officer Ipsen

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown

Section 1: Partner For Patient Centricity
08:30 - 09:00
The Business Case for long-term partnership with Patient Groups
  • Sustainable change: invest to strengthen the collaboration and improve trust with the patient community
  • How to shift from transactional value to deeper partnerships with patient groups
  • EPALCO Case Study: The Story of Novartis Oncology Region Europe on how working together with the Patient groups can improve outcomes for patients and make the industry a trusted partner

Novartis Oncology Europe Veronica Foote Head of Patient Relations & Communications Europe Novartis Oncology Europe

09:30 - 10:00
Want to improve patient outcomes? Collaborate with your competitors!
  • Why open-business models are the only way to reduce waste and achieve true change
  • Why pharma must work together to identify gaps in treatment pathways
  • Case Study: How AstraZeneca built a coalition for change

AstraZeneca Tim Scrivener Solution Architect and Data Scientist AstraZeneca

digitalECMT, Cancer Research UK and The Christie NHS Foundation Trust Jenny Royle Patient-centricity Program Lead digitalECMT, Cancer Research UK and The Christie NHS Foundation Trust

09:30 - 10:00
Panel: Accelerate the implementation of outcomes-focused value-based healthcare in Europe
  • Explore how the Innovative Medicines Initiative’s (IMI) Big Data For Better Outcomes (BD4BO) programme is facilitating collaboration across the healthcare landscape
  • Highlight the role and benefits of patients to improve health outcomes and contribute to the sustainability of healthcare systems
  • Discuss the development and utility of standardised patient outcomes measures

ABPI Shahid Hanif Head of Health Data & Outcomes ABPI

Christoph Thalheim Director External Affairs European Multiple Sclerosis Platform (EMSP)

Janssen Christina Donatti IMI Lead, Real-World Evidence Janssen

09:30 - 10:00
MS in the 21st Century; explore a unique collaboration between patients and healthcare professionals to address areas of unmet need in Multiple Sclerosis
  • Understand the ‘communication gap’ that exists between patients and healthcare providers (HCPs) with respect to disease management
  • See the programmes and publications the group has undertaken to address discovered unmet needs
  • Hear the patient perspective; why is this initiative so important for both patients and HCPs?

Merck Group Vanessa Pott Director, Patient Advocacy & Strategic Partnerships, Global Healthcare Government & Public Affairs Merck Group

David Yeandle, OBE Member MS in the 21st Century Patient Steering Group

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown

Section 2: Evidence for Patient Centricity
09:00 - 09:30
Advance market access through patient data and collaborations
  • How do you work with patients to capture patient reported outcomes?
  • What is the impact of PROs on Access dossiers?
  • Build trust through transparency to win the support of the patient

Janssen Global Services LLC Chenglong Han, MD, PhD. Director, Patient-Reported Outcomes, Global Market Access Janssen

09:00 - 09:30
Patient Privacy and GDPR - get it right and harness data for increased value
  • Understand the impact of GDPR on pharma’s ability to build data-driven services
  • How to evaluate the business of investing in AI and other data-dependent strategies
  • Take a step back: are data-driven strategies really the best way to meet patient needs?

Speaker to be announced

09:30 - 10:00
Maximise your data strategy for patient-centric service design
  • Define your data needs to prove internal and external value
  • How to mix internal capability, digital tools and partnerships to meet your data strategy
  • Learn how to transform insights into patient centric impact

Takeda Sanja Njegic Head of Patient Advocacy and Integrated Care Strategy, Europe and Canada Takeda

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown

Im-patient Summit – where patients are in charge!#impatientconf
09:00 - 09:30
Chairman’s Opening:

Matt will kick off the first ever im-patient conference with a message of inclusivity and why this is such an important step forward.

Chairman: -- Matt Eagles Patient Advocate

09:00 - 09:30
Innovation that works – when patients devise their own solutions

Patients suffering from chronic conditions often develop useful and innovative solutions to help them cope with their health disorders. If shared, these patient innovations could significantly impact the lives of others living under similar conditions.

  • Understand the huge scale of patient innovations that require support
  • The patient knows best – understand how empowerment can lead to pre-backed solutions
  • Witness some of the most exciting selections from the 1600 patient-led innovations submitted to an open online platform

Pedro Oliveira Pedro Oliveira Professor of Technology and Innovation Management, Católica Lisbon School of Business & Economics and Leader of Patient Innovation

09:30 - 10:00
Lise Pape, Carer and Founder of Walk With Path

Lise founded Walk With Path in 2014 when she identified a need through her personal experience with Parkinson’s suffered by her father. She used her Innovation Design Engineering background and the company launched its first product in 2017; Path Finder, a visual cueing shoe attachment to help those with Parkinson's. The second product, a haptic feedback insole to improve balance; Path Feel, is in development. Lise will share:

  • How she created a solution to this unmet need of many patients with Parkinson’s and other disease areas
  • Her approach to user centred design, critique of everyday wearables and her approach to co-creation.
  • Feedback and redesign: how patient experiences informed continued improvements.

Lise Pape Lise Pape Carer and Founder Walk With Path

09:30 - 10:00
Develop solution for day to day disease management

Let Andrew fly you on board his ‘blood sugar plane’, rising high and dipping low, in order that you can experience a real patient journey and the challenges that had to be overcome.

  • How recognition of a real patient experience led to the creation of a life-changing technical solution and better
  • How a patient’s decision-making process depends on good data feedback and impact on QOL

Andrew Warrington Andrew Warrington Type 1 Diabetes Patient

Interactive Roundtables
09:30 - 10:00
Interactive Roundtable:Scenario one: The clinical trial engagement roundtable debate

Every pharma executive wants to design clinical trials around patients – yet, consistently, we fail. It’s not due to a lack of budget – it’s a lack of strategy and understanding. Let’s start with the patient perspective and then progress to how we work with external partners.

  • Hear directly from patients on their preference for working with pharma clinical teams, and how do patients prefer to work with them
  • What is most effective at connecting and recruiting patients for the right clinical trials?
  • How can we work with external organisations better to locate trial patients better?
  • Where do external companies (e.g. Clara Health, CureClick etc.) need to improve, and how can patients help?
  • What innovations can pharma introduce to make the traditional RCT more effective for end users?
Interactive Roundtable:Scenario two: The pharmaceutical marketing roundtable debate

Pharma companies are well known for their impressive marketing and advertising budgets, but everybody knows that not all of that money is well spent. Let’s talk to patients about what resonates with them in pharmaceutical advertising and marketing — and what doesn’t.

Marketing Roundtable topics to be announced shortly

Roundtable moderators:

-- Cecile Tardy-Srinivasan Patient Advocate

-- Matt Eagles Patient & Patient Advocate

-- Simon Stones Patient Advocate

-- Richard Stephens Patient Carer

Logo Blank Margot Vanfleteren Patient Advocate

Emma Lawton Emma Lawton Devices Apps & Gadgets Strategist Parkinsons UK

-- Andrew Warrington Type 1 Diabetes Patient

-- Dom Raban Founder Xploro

-- Lisa Mackenzie Patient

Lise Pape Lise Pape Carer and Founder Walk With Path

09:30 - 10:00
Stakeholder Panel
09:30 - 10:00
Stakeholder PanelAdherence is always one of pharma’s goals. But is it the patient’s goal, too?
  • Start with the patient: Align with the patient community’s aspirations and life goals in order to improve treatment compliance and outcomes
  • What tools do patients crave? How to focus investments on demand rather than your technology or convenience
  • Educate adherence: enable more informed decision-making by enabling HCPs to aid transparency and communication with patients

-- Lisa Mackenzie Patient

-- Ben Harman Jones HCP

-- Emma Sutcliffe and her daughter Delilah

09:30 - 10:00
Digital Solutions
09:30 - 10:00
How a patient-inspired app is using AR, AI and game mechanics to deliver health information to children

In 2011, Dom Raban’s 13-year-old daughter, Issy, was diagnosed with a rare form of bone cancer. See how Issy’s year-long journey – involving 18 rounds of chemotherapy, surgery and Proton Therapy in the US – inspired a new mobile application:

  • The challenges of the complex patient journey, especially in children, and finding solutions to the information needs
  • How Issy’s experience led to an app using a variety of new technologies to deliver health information directly to children
  • How patients can lead the development process to improve quality, relevance and advocacy

-- Dom Raban Founder Xploro

09:30 - 10:00
The power of digitally-enhanced communication in the hands of the patient

See how Emma’s Parkinson’s diagnosis, at the age of 29, has led to a new support platform for thousands of patients. Making it her mission to raise awareness about the condition and continue her life as planned, Emma campaigned on social media, published her own book, featured in a BBC documentary and video-blogged her life for a whole year.

  • Witness how Emma’s experience has led to the creation of Threesixfives, a website where people with long term health conditions can learn and find support
  • Understand patient literacy and the potential reach of good storytelling
  • How Parkinson’s UK is using technology to enhance lives – and the opportunity for pharma

Emma Lawton Emma Lawton Devices Apps & Gadgets Strategist Parkinsons UK

09:30 - 10:00
Followed by a Q&A with Dom and Emma, Moderated by Simon Stone

Moderator: -- Simon Stones Patient Advocate

-- Dom Raban Founder Xploro

Emma Lawton Emma Lawton Devices Apps & Gadgets Strategist Parkinsons UK

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown

Section 3: Structure for Patient Centricity
09:00 - 09:30
Discover the organisational blueprint for scaling patient centricity
  • Smart ways to ensure a grassroots movement into a new way of working
  • Build organisational confidence to embed patient engagement into everything you do
  • Case Study: The story of Janssen’s hub for scaling patient engagement

Janssen Pharmaceutical NV. Daniel De Schryver Patient Engagement and Advocacy Lead, Europe, Middle East and Africa Janssen

Jeremy Taylor Patient Advocate

09:30 - 10:00
Panel: Involve the patient voice while staying within industry rules
  • Learn to engage and speak with patients
  • Earn the trust of patients and retain the trust of colleagues and regulators
  • Balance internal investment and external partnerships to harness patient insights
  • How to negotiate tensions between industry rules and patient advocates and groups

NCRI Richard Stephens Consumer Lead and Chair of Consumer Forum NCRI

Carol Munt Patient Advocate

More speakers to be confirmed…

Download your event brochure

Full speaker list • Full conference agenda • Audience breakdown

Section 4: Patient Experience for Patient Centricity
09:00 - 09:30
Create services that resonate through co-creation and ethnography
  • Dig beneath the surface to truly understand the patient
  • Shift from patternistic design to co-creation led by patients
  • Move from a business model framework to a patient experience framework of service design

Pfizer Geoff Rollason Patient Experience and Service Director - Oncology UK Pfizer

09:00 - 09:30
Design for Patients As People
  • Generic programs fail fast: Create responsive programs for the full spectrum of patient needs
  • Develop a master plan for segmented engagement
  • Create new mechanisms to incorporate feedback into service delivery

Speaker to be confirmed…

08:30 - 09:00
Explore how Pfizer are vitalising patient engagement through co-created digital innovation
  • Identify what ‘improve delivery of healthcare’ will mean for the quality of patient care
  • Accelerate digital progress through collaboration to understand patient preferences

Doris Christiane Schmitt Consulting and Training Doctor-Patient-Communication

Pfizer Christina Claussen Director Alliance Management & Patient Relations for Corporate Affairs Pfizer

09:00 - 09:30
Panel: Candid patient perspectives on the good, the bad and the ugly of service design
  • How do patients really experience pharma’s services?
  • Can pharma better build trust with patient communities to develop productive collaborations?
  • Innovation is supposedly the ‘silver bullet’, but where do patients really see the opportunity for change?

Speaker_Logo Teresa Ferrairo Patient Advocate

Trishna Bharadia Patient Advocate eyeforpharma Award Winner

Carole Sian Scrafton MBS, BA (hons) Patient Advocate

AISC Paola Antonini, MD, PhD AISC Scientific Committee Member, Head of Clinical Research & Training Initiatives AISC

More speakers TBA

Download the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown